Back to Search
Start Over
IGLV3-21$^{R110}$ mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia
- Source :
- Nadeu, Ferran; Syrykh, Charlotte; Pons-Brun, Berta; Russiñol, Núria; Playa-Albinyana, Heribert; Baumann, Tycho Stephan; Duran-Ferrer, Martí; Kulis, Marta; Carbó-Meix, Anna; Mozas, Pablo; Alcoceba, Miguel; González, Marcos; Navarro-Bailón, Almudena; Colado, Enrique; Payer, Ángel; Aymerich, Marta; Terol, María José; Lu, Junyan; Knisbacher, Binyamin Asher; Hahn, Cynthia K; Ruiz-Gaspà, Sílvia; Enjuanes, Anna; Wu, Catherine J; Getz, Gad; Zenz, Thorsten; López-Guillermo, Armando; Martin-Subero, Jose I; Colomer, Dolors; Delgado, Julio; Campo, Elías (2023). IGLV3-21$^{R110}$ mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances, 7(23):7384-7391.
- Publication Year :
- 2023
Details
- Database :
- OAIster
- Journal :
- Nadeu, Ferran; Syrykh, Charlotte; Pons-Brun, Berta; Russiñol, Núria; Playa-Albinyana, Heribert; Baumann, Tycho Stephan; Duran-Ferrer, Martí; Kulis, Marta; Carbó-Meix, Anna; Mozas, Pablo; Alcoceba, Miguel; González, Marcos; Navarro-Bailón, Almudena; Colado, Enrique; Payer, Ángel; Aymerich, Marta; Terol, María José; Lu, Junyan; Knisbacher, Binyamin Asher; Hahn, Cynthia K; Ruiz-Gaspà, Sílvia; Enjuanes, Anna; Wu, Catherine J; Getz, Gad; Zenz, Thorsten; López-Guillermo, Armando; Martin-Subero, Jose I; Colomer, Dolors; Delgado, Julio; Campo, Elías (2023). IGLV3-21$^{R110}$ mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia. Blood Advances, 7(23):7384-7391.
- Notes :
- application/pdf, info:doi/10.5167/uzh-239059, English, English
- Publication Type :
- Electronic Resource
- Accession number :
- edsoai.on1443053793
- Document Type :
- Electronic Resource